MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about certificate

07 Oct 2021 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of the Certificate received from Kfintech Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th September 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..